MarketEquus Total Return And 7 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Sep 22, 2024
MarketAssured Guaranty Ltd. And 7 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Sep 13, 2024
MarketTG Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Sep 6, 2024
MarketTG Therapeutics And 6 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Aug 20, 2024
MarketTG Therapeutics And 6 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Aug 12, 2024
MarketTG Therapeutics And 4 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Aug 6, 2024
MarketTG Therapeutics And 6 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Jul 23, 2024
MarketTG Therapeutics And 6 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Jul 10, 2024
MarketTG Therapeutics And 4 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Jul 3, 2024
MarketTG Therapeutics And 5 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Jul 3, 2024
MarketKrystal Biotech And 4 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Jun 15, 2024
MarketEquus Total Return And 4 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•May 30, 2024
MarketIamgold Corporation Ordinary Shares And 3 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•May 28, 2024
MarketTG Therapeutics And 6 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Apr 28, 2024
MarketTG Therapeutics And 6 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Mar 31, 2024
MarketTG Therapeutics And 3 Other Stocks Have High Sales Growth And An Above 3% Return on EquityViaNews Editorial Team•Mar 17, 2024
